Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far?

Table 8

Overall survival and biochemical failure free survival by therapeutic modality, adapted from Cho et al. (2016) [16].

Therapeutic modality	3-year OS rate (%)	BCFFS (%)
TP	48,2	25,0
RT	69,0	52,0
NLT	43,0	16,0
Palliative RT	50,0	10,0
Without palliative RT	40,0	20,0

OS: overall survival; BCFFS: biochemical failure-free survival; TP: total population; RT: radiotherapy; NLT: no local treatment.